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Anti- or profibrillatory effects of Na+ channel blockade depend 
on the site of application relative to gradients in repolarization
Ruben Coronel*, Francien J. G. Wilms-Schopman and Michiel J. Janse
Experimental Cardiology Group, Academic Medical Center, Amsterdam, Netherlands
Sodium channel blockers are associated with arrhythmic sudden death, although they are 
considered antiarrhythmic agents. The mechanism of these opposing effects is unknown. We 
used a model of induction of ventricular fibrillation (VF) based on selective perfusion of the 
vascular beds of isolated porcine hearts (n = 8). One bed was perfused with sotalol (220 μM), 
the adjacent bed with pinacidil (80 μM), leading to repolarization heterogeneity (late repolarization 
in the sotalol-, early in the pinacidil-area). Premature stimulation from the area with the short 
action potential was performed. Epicardial activation/repolarization mapping was done. In 
three of the eight hearts VF was inducible prior to infusion of flecainide. In those hearts the 
Fibrillation Factor (FF), the interval between the earliest repolarization of the premature beat 
(S2) in the early repolarizing (pinacidil) domain, and the last S2-activation in the late repolarizing 
(sotalol) domain, was significantly shorter than in the hearts without VF (33 ± 22 vs 93 ± 11 ms, 
m ± SEM, p < 0.05). In the three hearts with VF flecainide was infused in the pinacidil domain 
after defibrillation. This led to shortening of the line of block, local delay of S2 activation and 
repolarization, an increase in FF and failure to induce VF . In the five hearts without VF , flecainide 
was subsequently infused in the sotalol domain. This led to a local delay of S2 activation, a 
shortening of FF (by 47 ± 3 ms) and successful induction of VF in three hearts. In the two 
remaining hearts FF did not decrease enough (maximally 13 ms) to allow re-entry. Sodium 
channel blockade applied to myocardium with a short refractory period is antifibrillatory whereas 
sodium channel blockade of myocardium with a long refractory period is profibrillatory. Our study 
provides a mechanistic basis for pro- and antiarrhythmic effects of sodium channel blockers in 
the absence of structural heart disease.
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illustrates our hypothesis. In the presence of a preexisting repolariza-
tion gradient a premature stimulus (S2) is delivered to the zone with 
the short action potential. The difference between the repolarization 
time of the premature beat in the tissue proximal to the line of block 
and the activation time of the premature activation front distal to the 
line of block determines whether or not re-entry occurs (Coronel 
et al., 2009). We have termed this difference the “Fibrillation Factor” 
(FF). When FF is small there is unidirectional conduction block and 
re-entry occurs, but when it is large the premature wavefront meets 
a line of bidirectional block and re-entry is prevented.
Figure 1A shows a condition prior to the infusion of flecain-
ide, when re-entry does not occur, because the wavefront traveling 
around the line of block reaches the distal site at a time when the 
proximal zone has not yet recovered from excitability (FF is large). 
We hypothesize that by adding flecainide to the distal zone, the wave-
front in the distal zone is delayed and now arrives late enough for the 
proximal tissue to be re-excited (FF has become smaller). If prior to 
application of sodium channel blockade VF does occur (FF is small, 
Figure 1B), administration of flecainide to the proximal tissue causes 
a delay of local activation (and therefore repolarization) so that the 
wavefront reaches the distal site too early to allow re-entry (FF has 
increased). In this scenario, conduction slowing in the distal area is 
proarrhythmic, whereas conduction slowing in the proximal area is 
IntroductIon
Sodium channel blockade was originally considered an antiarrhyth-
mic strategy (Lie et al., 1978; Coromilas et al., 1995). The CAST-
study,  however,  has  demonstrated  that  it  also  may  provoke 
arrhythmic  death  (The  Cardiac  Arrhythmia  Suppression  Trial 
[CAST] Investigators, 1989). Also, loss of function mutations in 
sodium channel are associated with life-threatening arrhythmias 
(Zimmer and Surber, 2010). Slowing of conduction in the pres-
ence of an arrhythmogenic substrate (acute myocardial infarction 
or fibrosis associated with heart failure) is a common explanation 
for the proarrhythmic effect of sodium channel blockers in the 
CAST study (Echt et al., 1991). It is, however, not clear by which 
mechanism sodium channel blockade can be proarrhythmic in 
the absence of structural abnormalities. We addressed this ques-
tion in an porcine model of ventricular fibrillation (VF) based on 
heterogeneity in repolarization (Coronel et al., 2009).
In a previous study (Coronel et al., 2009) we have shown that 
repolarization heterogeneity may lead to conduction block, but not 
necessarily to re-entry. In the present study we slowed conduction 
by regional infusion of the sodium channel blocker flecainide, and 
hypothesized that conduction slowing by sodium channel block-
ade can be either pro- or antiarrhythmic depending on the area 
of administration relative to the repolarization gradient. Figure 1 
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The Netherlands, Janssen-Cilag, High Wycombe, UK), and 0.5 mg 
atropine  (Centrafarm  Services,  Etten-Leur,  The  Netherlands) 
intramuscularly and anesthetized with 20 mg/kg pentobarbital 
(Nembutal,  CevaState Animale,  Naaldwijk,  The  Netherlands) 
intravenously.  The  animals  were  intubated  and  ventilated 
with  room  air  and  isoflurane  (Forene,  Abbott,  Hoofddorp, 
The  Netherlands).  Expiratory  CO2  was  monitored.  Heparin, 
5000 international units (LeoPharma, Breda, The Netherlands) 
was injected intravenously. Blood was collected, and the heart 
was isolated via a midsternal thoracotomy.
The heart was perfused in a Langendorff setup using a mixture 
of blood and Tyrode’s solution (pH = 7.35–7.45). Atrioventricular 
block was created by crushing the AV nodal area. The left ante-
rior descending coronary artery (LAD) was freed over a distance 
of 5 mm, above the first diagonal branch. A ligature was passed 
antiarrhythmic. This hypothesis was tested in this study in which 
we specifically addressed the question whether regional infusion of 
a sodium channel blocker would cause an increase or decrease in FF 
and a concomitant corresponding anti- or profibrillatory effect.
MaterIals and Methods
This study was approved by the local ethical committee on animal 
experimentation and conforms to the Guide for the Care and Use of 
Laboratory Animals published by the National Institute of Health 
(NIH publication No. 85-23, revised 1996).
PreParatIon
Pigs (n = 8; weight 37.5 ± 1.8 kg (mean ± SEM)) were pre-
medicated with 350 mg ketamine (Nimatek, Animal Health BV, 
Bladel, The Netherlands), 80 mg azaperone (Stresnil, Janssen, 
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Figure 1 | Diagram of the hypothesis. (A,B) Each show two hypothetical 
action potential tracings from two sides of a region of repolarization 
dispersion. The distal (dist.) side of this region has a prolonged action potential 
compared to the proximal side (prox.). Each tracing shows the response of a 
basic stimulus (S1) and a premature stimulus (S2). The S2 is conducted with a 
delay towards the distal side because of unidirectional block between the 
regions. The Fibrillation Factor (FF) is defined by the difference in proximal 
repolarization time and the distal activation time of the premature beat 
following S2. If no re-entry can be induced infusion of sodium channel 
blockade into the distal region (A, distal) shifts the distal activation time of S2 
to a later moment (the dotted line represents the action potential before 
flecainide), decreases FF and results in re-entry. (B) Shows the mirror 
condition. If VF can be induced, prolongation of the FF can be achieved by 
sodium channel blockade of the proximal tissue, leading to a delay of proximal 
S2 repolarization secondary to the delay in activation, and an antifibrillatory 
effect (B, proximal). The diagrams (right) show the corresponding activation 
patterns. Distal application of sodium channel blockade leads to the conversion 
of idirectional block to unidirectional block, proximal application of sodium 
channel blockade to conversion from unidirectional block to bidirectional block 
(red line).www.frontiersin.org  June 2010  | Volume 1  | Article 10  |  3
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Contrary to our previous study where pinacidil was infused in 
the LAD area and sotalol in the remainder of the heart, we now 
infused sotalol in the LAD and pinacidil in the rest of the heart. 
To facilitate comparison with the activation maps in that study we 
rotated the activation maps 180°. The FF is defined as the differ-
ence between the activation time of the premature activation front 
distal to the line of block and the repolarization time of the tissue 
proximal to the line of block (Coronel et al., 2009).
Protocol
At time zero (t = 0), the LAD was perfused with the normal blood-
Tyrode’s mixture, and pinacidil was administered to the rest of 
the heart (the proximal zone) to shorten the repolarization time. 
At t = 10 min, sotalol was added to the LAD area (distal zone) to 
prolong local repolarization time. Before one recirculation period 
expired, recirculation was stopped and the venous blood was not 
reentered into the perfusion apparatus. From this moment onward 
a stable condition could be maintained for about 30 min until we 
ran out of perfusate.
We attempted to induce VF by a premature stimulus applied 
to the proximal zone from t = 15 to 18 min. If VF occurred within 
this period, the heart was defibrillated immediately and flecainide 
was added to the proximal zone. If VF did not occur,   flecainide was 
added to the distal area while the combination of the perfusate was 
otherwise maintained. Subsequent attempts to induce VF were made 
between 22 and 30 min. As many recordings as possible were made 
of the premature beats and any ensuing arrhythmias from the time 
at which repolarization heterogeneity was created by selective per-
fusion with the drugs. When VF occurred, the heart was immediately 
defibrillated by a DC shock, stimulation was resumed and a period 
of 1 min was allowed before induction of VF was re-attempted. The 
selection of the relevant successful and unsuccessful attempts to 
induce VF was made on the following grounds. First, pacing was per-
formed with the same coupling interval and from the same stimulus 
site before and after flecainide. Second, VF induction immediately 
before administration of flecainide was compared to VF-induction 
at the moment on which the maximum conduction slowing induced 
by flecainide occurred. As a result of this selection we were able to 
compare 8 pairs of total of 68 VF-inductions.
drugs
Sotalol (Sotacor vials 10 mg/ml) was obtained from Bristol–Myers–
Squibb (Woerden, The Netherlands). Pinacidil (pinacidil monohy-
drate P154) was obtained from Sigma Aldrich (Zwijndrecht, The 
Netherlands), Tambocor (flecainide acetate) from 3 M Nederland 
(Zoeterwoude, The Netherlands).
PresentatIon of data and statIstIcal analysIs
Data are presented as mean ± standard error of the mean (SEM). 
Comparisons were tested for differences with the use of the paired 
t-test or the Mann–Whitney Rank Sum test, when appropriate 
p < 0.05 was accepted as the level of statistical significance.
results
The magnitude of differences in repolarization time obtained by 
infusion of sotalol and pinacidil was on average 96 ± 11 ms (n = 8). 
In three of the eight hearts VF was inducible prior to infusion of 
underneath the LAD, and a cannula was introduced via a small 
incision into the LAD. The cannula was fixed by tying the ligature 
and was connected to a separate perfusion system via a miniature 
heat exchanger. The temperature of both perfusion areas was con-
trolled by separate heat exchangers in each perfusion limb. Infusion 
pumps were connected to the side branch of the LAD cannula 
and to the aortic cannula for the administration of sotalol and/or 
flecainide. Pinacidil was added to the perfusate by mixing it in the 
main container to reach a final concentration of 80 μM.
Infusion pump rates were adjusted to obtain calculated concen-
trations of 220 μM sotalol and 6 μM flecainide. The LAD perfused 
area had a temperature of 37.6 ± 0.30°C, the remainder of the heart 
was at 37.4 ± 0.23°C. Flow in the LAD was set at 30 ml/min, flow 
in the remainder of the heart at 70 ml/min. The absence of ST-T 
segment changes indicated absence of local ischemia (recording 
methods see below).
Flecainide was selectively infused in either vascular bed, depend-
ing on the preexisting inducibility of VF.
electroPhysIology
A rectangular grid of 11 × 11 electrodes (gold, 5 mm interelectrode 
distance) was sutured over the border between the myocardium 
perfused by the LAD and the rest of the heart. The cyanotic border 
was identified prior to application of the electrode by a 30-s occlu-
sion of the LAD. Correct positioning of the electrode was verified 
by creating a 5-min occlusion of the LAD and analyzing the border 
between the region with and without electrophysiological signs of 
ischemia. After restoration of blood flow the heart was allowed 
to recover for at least 60 min before measurements were begun. 
Full recovery was defined by the return of ST-segment elevation 
to the isoelectric line and a stable value of refractoriness in the 
LAD-area.
Unipolar cathodal stimulation was performed through one of 
the electrodes in the electrode grid overlying the circumflex area. 
One to three stimulus positions were tested sequentially. The anode 
was placed at the aortic root. Premature beats were introduced after 
each train of eight beats with coupling intervals ranging from the 
basic cycle length of 600 ms down to the refractory period. Control 
recordings were made of a basic beat and a premature beat prior 
to the interventions. Local unipolar electrograms were recorded 
against a reference electrode at the aortic root using a data acquisi-
tion system [Biosemi, Amsterdam, The Netherlands, sampling rate 
2000 Hz, filtering DC 1 kHz (3 dB)].
Analysis of the electrograms was performed offline using a 
custom-made analysis program (Potse et al., 2002). Local acti-
vation times were measured at the moment of the minimum 
dV/dt of the initial deflection, and local repolarization times 
at the moment of the maximum dV/dt of the T wave (Coronel 
et al., 2006). When determination of activation times was dif-
ficult because of fractionation of the signals, Laplacian electro-
grams were constructed to aid in the detection of local activation 
(Coronel et al., 2000). Regional conduction delay induced by 
flecainide was quantified by averaging activation times within 
the respective perfusion domains, before and after administra-
tion of flecainide. In the distal tissue, the local activation times 
were corrected for the time of arrival of the activation wave in 
the distal domain.Frontiers in Physiology  |  Cardiac Electrophysiology    June 2010  | Volume 1  | Article 10  |  4
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The lower panels of Figure 2 show activation maps after the 
addition of flecainide to the distal zone. The activation pattern 
of the proximal area is unaltered compared to the top panel. The 
wavefront reaches the tissue distal to the line of block after 380 ms, 
much later than before infusion of flecainide, and now is able to 
re-excite the proximal tissue after 428 ms, leading to VF. The repo-
larization time of the proximal tissue is 403 ms (not shown). The 
pattern of the isochrones suggests that the tissue distal to the line 
of block is activated from deeper layers. The local electrograms, 
recorded from the same sites as in the top panel now demonstrate 
that the time difference between local distal S2 activation (dotted 
line) and proximal S2 repolarization (dot) has decreased.
Figure 3 shows an example of two electrograms simultaneously 
recorded from the proximal (red) and distal (blue) perfusion beds. 
With longer distal exposure to flecainide local S2 activation (dotted 
line) is progressively delayed in the distal domain, until it encroaches 
on the proximal S2 repolarization (circle) and VF ensues (bottom).
flecainide. As expected, the FF was significantly shorter in the hearts 
with VF than in the hearts without VF (33 ± 22 vs 93 ± 11 ms, 
m ± SEM, p < 0.05).
Figure 2 shows an example of the proarrhythmic effect of the 
application of flecainide to the myocardium with late repolariza-
tion. Maps are shown of activation times following application 
of a premature stimulus to the proximal zone (p, pinacidil) with 
a coupling interval of 260 ms. Prior to flecainide infusion (top 
panels) the premature wavefront arrives after 340 ms at the tis-
sue distal to the line of block, too early to re-excite the proximal 
tissue which has a repolarization time following S2 of 401 ms 
(not shown). Hence no VF ensues. Selected electrograms from 
either regions show that the T-wave is positive in the area with 
the pinacidil (proximal, p) and predominantly negative in the 
area with sotalol (distal, d). The premature activation of the 
distal area is early (dotted line) relative to the proximal repo-
larization (dot).
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Figure 2 | Activation maps of the premature beat (following S2) before 
and after application of flecainide (flec) to the region with prolonged 
repolarization (distal). Prior to infusion of flecainide no VF could be induced, 
because local distal activation preceded local proximal repolarization. Flecainide 
infusion the distal domain caused a decrease of the FF and induction of VF . The 
dashed line indicates the epicardial interface between the perfusion beds. Small 
dots indicate electrode positions. Bold dots indicate positions from which 
electrograms (right panels) were recorded (p, proximal; d distal). Lines are 20 ms 
isochrones. Red dotted vertical line in the electrograms indicate the moment of 
distal activation.www.frontiersin.org  June 2010  | Volume 1  | Article 10  |  5
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(1) the later arrival of the activation wave at the interface between 
the perfusion beds causes a shortening of the line of block and 
therefore an earlier arrival of the activation wave at the distal side 
of the line of block (after 371 ms, compared to 394 ms before fle-
cainide) (2) the proximal S2 repolarization time increased from 
382 to 401 ms. These two combined effects of flecainide cause the 
impulse to arrive too early at the distal side of the block relative 
to proximal S2 repolarization. This causes an increase in FF and 
failure to induce VF.
Overall, a re-entrant activation pattern was mapped in three 
of the six hearts that fibrillated. In the other hearts a complete 
re-entrant pathway was not demonstrable, but the FF could be 
calculated. In Figure 6 the FF before and after administration of 
flecainide is plotted for the three hearts in which flecainide applied 
to the distal zone converted a bidirectional line of block (without 
re-entry) into a unidirectional block and to VF. Proarrhythmia was 
associated with a decrease of the FF induced by flecainide. In the 
two hearts in which flecainide was given distally, the shortening 
of the FF was not enough to cause re-entry. In three hearts that 
fibrillated before administration of flecainide, the drug infused 
in the proximal zone prolonged the FF, and VF could no longer 
be induced.
Regional infusion of flecainide into the proximal region led to 
an activation time delay of both the basic and premature beats (S1 
and S2) of about 7 ms (averaged activation time differences in the 
proximal perfusion domain) (Figure 4A). As expected (flecainide 
was not infused in this domain) propagation in the distal perfusion 
domain was not affected (not shown).
When flecainide was infused in the distal area (as in Figure 2) 
the local-distal-activation delays of S1 were of similar magnitude 
as after infusion in the proximal area. However, activation delays 
following S2 were larger related to the activation path that was 
longer after S2 than after S1. Distal flecainide infusion did not 
affect proximal activation times (not shown), as expected. The 
activation delay induced by flecainide was statistically significant 
both for S1 and S2 (p < 0.001, n = 8 each, Mann–Whitney Rank 
sum test).
Figure 5 shows the antiarrhythmic effect of flecainide when 
administered to the proximal zone. Before the infusion of flecai-
nide, a premature impulse given after 240 ms causes re-entry and 
VF. The premature wavefront arrives at the distal side of the line 
of block after 394 ms while the repolarization time of the proximal 
tissue is 382 ms (not shown), hence FF is small. The conduction 
slowing of the S2 beat induced by flecainide has a twofold effect: 
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Figure 3 | example of two electrograms simultaneously recorded from 
the myocardium proximal (red) and distal (blue) from the interface 
between the perfusion beds. Proximal tissue was perfused with pinacidil, 
distal tissue was perfused with sotalol. The last basic beat and the first 
premature beat are shown before (top) and several minutes after infusion of 
flecainide into the distal (blue) domain. With longer exposure to flecainide local 
activation (dotted line) is progressively delayed in the distal domain, until it 
encroaches on the proximal S2 repolarization (circle) and VF ensues (bottom).Frontiers in Physiology  |  Cardiac Electrophysiology    June 2010  | Volume 1  | Article 10  |  6
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Figure 6A shows a summary of all VF-induction attempts as a 
function of FF. Observations were binned in FF classes of 20 ms. 
With decreasing FF, the proportion of VF induction was more 
successful. Figure 6B shows the change of FF of the eight paired 
observations of VF induction as a function of the activation delay 
induced by flecainide in each of the perfusion beds. Note that the 
left panel of the figure shows increased activation delay caused by 
proximal and the right panel activation delay caused by distal infu-
sion of flecainide. The symbols indicate whether a change in induc-
ibility of VF occurred (white VF, black no VF). The experiments in 
which no change in VF inducibility occurred were characterized by 
a small change in FF and a small change in activation time.
dIscussIon
In this study we have demonstrated that sodium channel block-
ade can be either proarrhythmic or antiarrhythmic depending 
on its site of application relative to the repolarization gradient. 
We chose a model of induction of VF based on heterogeneity in 
repolarization (Coronel et al., 2009) in which VF can be reproduc-
ibly induced after premature stimulation from the area with the 
shorter repolarization time(Coronel et al., 2009). The differential 
effect of sodium channel blockade depends on the timing of the 
arrival of the premature activation at the distal side of the line of 
activation block relative to repolarization of the proximal side 
(the Fibrillation Factor, FF), which is critical for the induction of 
re-entry and VF. A reduction of FF is associated with a profibrilla-
tory effect and can be achieved by application of sodium channel 
blockade to the site with the longer action potential duration. 
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Figure 4 | regional flecainide (flec) infusion causes activation delay in the 
respective regions following a basic beat (S1) and a premature beat (S2), and 
both during proximal (panel A)and distal (panel B) application of flecainide. 
After S2 conduction delays are more pronounced when flecainide is infused in the 
distal region than in the proximal regional, because the activation pathway is longer 
than in the latter. Distal activation times were calculated relative to the earliest 
arrival at the border between the perfusion beds. Activation delays in the domain 
not perfused with flecainide, no change in activation time occurred (not shown).
Conversely, an   antifibrillatory effect can be produced by sodium 
channel   blockade of the tissue with the short action potential. 
Our study shows that a small delay of activation (see Figure 4, 
about 7 ms.) caused by infusion of flecainide makes the difference 
between successful induction of VF or not.
Activation delay induced by sodium channel blockade has two 
effects relevant for the magnitude of the FF: In the case of con-
duction slowing in the area with short action potentials it delays 
the arrival of the premature wavefront to the tissue with pro-
longed action potential duration and thereby shortens the area 
of (proximal) activation block, causing earlier activation of the 
tissue distal to the line of block. Furthermore, it secondarily delays 
repolarization of the premature wave and thereby increases the FF 
(antiarrhythmic). Conversely, conduction slowing of the basic beat 
in the tissue with prolonged repolarization delays repolarization 
further, causing a lengthening of the line of proximal activation 
block. Also, the premature wavefront is delayed causing a reduc-
tion of the FF.
 Han and Moe (1964) formulated in 1964 the concept that het-
erogeneity in refractory periods was proarrhythmic. Boineau et al. 
(1980) published activation maps of “figure of 8” re-entry in the 
canine atrium, induced by a premature stimulus applied to the site 
with the shortest refractory period, in an atrium with large inho-
mogeneities in refractory periods (ranging from 150 to 210 ms). In 
the same year, re-entry leading to VF in response to a spontaneous 
premature beat was described in acutely ischemic myocardium 
(Janse et al., 1980). Again, this was partly due to large inhomogenei-
ties in refractory periods, those at the normal side of the ischemic www.frontiersin.org  June 2010  | Volume 1  | Article 10  |  7
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Figure 5 | Activation maps of the premature beat (following S2) before 
and after application of flecainide to the region with shortened 
repolarization (proximal). Prior to infusion of flecainide (flec) VF could be 
induced, because local distal activation coincided with local proximal 
repolarization. Flecainide infusion into the proximal domain caused an increase 
of the FF and failure of induction of VF . The increase of FF was reached by two 
mechanisms: first the proximal line of block was shortened because the 
activation front reached the line of block later. This also led to an earlier activation 
of the tissue distal to the line of block. Second because proximal S2 
repolarization was delayed. Symbols as in Figure 2.
border, where the premature beat originated, being short, those 
in the center of the ischemic zone being long. The differences in 
refractory period amounted to more than 100 ms (Capucci et al., 
1985). Kuo et al. (1983) created differences in ventricular action 
potential duration by local warming during global hypothermia. 
They found that in the presence of regional differences in action 
potential duration of 111 ± 16 ms, a premature stimulus delivered 
to the region with the shortest action potential induced arrhyth-
mias. In our previous study (Coronel et al., 2009) we showed that 
although a repolarization gradient is a prerequisite for the occur-
rence of conduction block, the restitution properties of the tissue 
with the shorter repolarization time determines whether or not 
re-entry occurs. If the “FF” is small, re-entry occurs, if it is large 
there is bidirectional conduction block.
Earlier studies have shown that drugs that flatten the restitution 
curve, such as calcium channel blockers, the electro-mechanical 
uncoupler diacetyl monoxime, and bretylium, did indeed prevent 
the induction of VF and converted existing fibrillation into a regular 
rhythm (Riccio et al., 1999; Garfinkel et al., 2000; Gelzer et al., 2008). 
We expect that flattening of the restitution curve will prolong the 
FF and will be antifibrillatory, independent of the maximum slope 
of the restitution curve.
In  all  cases  of  flecainide  infusion,  a  statistically  significant 
increase in activation time following S1 and S2 occurred within 
the relevant domain (Figure 4). It is remarkable that a small dif-
ference in activation time can have a large effect on VF inducibility. 
The activation maps presented in this and a previous study make 
clear that the critical arrival time of the activation wave at the distal 
side of the border relative to proximal repolarization is a matter of 
milliseconds. In this regards the FF resembles the all or none effect 
of cardiac activation following refractoriness.
It is conceivable that the beta-blocking effects of sotalol may 
have contributed to the observed effects. However, we did pace the 
heart at a regular heart rate and the antiarrhythmic bradycardic Frontiers in Physiology  |  Cardiac Electrophysiology    June 2010  | Volume 1  | Article 10  |  8
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Figure 6 | (A) Percentage of successful inductions of VF in bins of 20 ms FF. 
With increasing FF the induction success decreases. Numbers represent all 
induction attempts in eight experiments. (B) Individual paired observations 
(see Materials and Methods) of the relation between the S2-activation delay 
induced by flecainide and the FF . The symbols indicate the inducibility of VF 
before and after application of flecainide (white VF , black no VF , left before, right 
after flecainie). The left panel represents increase in activation delay in the 
proximal (pinacidil) domain, the right panel activation delay in the distal (sotalol) 
domain. Slowing of activation in the proximal domain is antiarrhythmic, 
slowing in the distal domain is proarrhythmic.
effects of beta-blockade can be excluded. Secondly, the pro- and 
antifibrillatory effects of flecainide were tested under similar con-
ditions, both in the presence of sotalol and pinacidil. Also, flecain-
ide has been described to block potassium currents and therefore 
may have influenced the repolarization gradients. We did observe 
an increase in repolarization gradient after application of flecai-
nide in some experiments. However, conduction slowing in itself 
also contributes to this effect. Indeed, after proximal application 
of flecainide the increase in conduction delay was, on average of 
the same magnitude as the increase in repolarization. Therefore, 
the potassium blocking affects of flecainide probably have played 
a minor role in our results. A possible explanation for this is that 
sodium channel blockade also reduces the contribution of the 
sodium current to the action potential plateau and thereby reduces 
action potential duration.
The model of VF inducibility based on large and steep gradients 
in repolarization that we have used is artificial and likely does not 
directly reflect a pathophysiological condition. However, the model 
resembles that of acute myocardial ischemia (Janse et al., 1980), 
where conduction slowing coincides with repolarization hetero-
geneity and where a premature beat originates from the area with 
the shorter repolarization. These conditions combine into the ideal 
small FF for the induction of VF. Furthermore, it is difficult to 
extrapolate our finding to the clinical condition where sodium 
channel blockers are systemically administered. Whether sodium 
channel blockers will be pro- or antiarrhythmic depends on which 
of the two opposing effects predominate.
It is remarkable that large repolarization gradients are required 
for the induction of VF, and that VF does not occur spontane-
ously, even in these extreme conditions. The line of activation 
block occurring upon premature stimulation from the area with 
the shorter repolarization depends on the coupling interval and the 
site of stimulation. If the premature beat originates closely from 
the border immediately after recovery from inactivation, the line of 
block is longest and is more likely to lead to re-entry and VF.
The model is limited by the restricted time frame in which 
measurements can be made. Therefore long term effects of the 
drugs cannot be studied. Secondly, only epicardial mapping was 
performed and no information is present about the intramural 
gradients of repolarization. On the other hand, the experiments 
address the question whether flecainide is able to prevent of facili-
tate the induction of VF. This is independent of the location of the 
mapping electrode.
Interventions aimed at increasing conduction velocity are 
therefore expected to be antiarrhythmic. Indeed, in the 1-week 
old canine myocardial infarction model this has been demon-
strated (Lau et al., 2009). Alternatively, local RNA interference 
by siRNA to suppress local sodium channel function could be 
applied to the area of the earliest repolarization time in order 
to prevent reentrant arrhythmias. Because a positive T-wave 
indicates tissue with early repolarization and a negative T-wave 
a region with late repolarization, this may open the way for 
gene therapy directed by the morphology of the T-wave of the 
local electrogram.
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